Scioto Biosciences

Indianapolis, Indiana, United States

Therapeutics Biotech Drug Development Gastroenterology

Scioto Biosciences is a Clinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics. Our team has developed a proprietary Activated Bacterial Therapeutics (ABT) platform for delivering best-in-class, live therapeutic bacteria to the gut. Our solution is focused on the activation of beneficial bacteria that have the potential to advance healing for various diseases associated with the GI tract, Oncology and CNS indications.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Scioto Biosciences on @MedStartr Today #DigestiveDiseases #CNSDisorders #Gastroenterology #Therapeutics #Biotech #DrugDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/nI-LfmdhJig

Get Involved in Scioto Biosciences

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: sciotobiosciences.com/

Disease Areas

Digestive Diseases CNS Disorders Gastroenterology

Technologies

PlatformBiotechnologyTherapeuticsMicrobiome Therapeutics

🌐Website

What do you think of Scioto Biosciences?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.